New Jersey Hematology Oncology Associates

Brick, New Jersey 8724

0 studies enrolling now · 10 studies all time

What they study most

Acute Myeloid Leukemia (AML), Breast Cancer, Breast Neoplasms, Cancer, Chronic Myelomonocytic Leukemia (CMML), Gastric Cancer, HER-2 Positive Breast Cancer, Metastatic Castration-resistant Prostate Cancer, Metastatic Neoplasm, Myelodysplastic Syndrome (MDS), NSCLC, Neutropenia

Studies at this site

• Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML — Recruiting now
• Development and Validation of Harbinger Health Test for Early Cancer Detection — Completed
• Margetuximab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy in the Treatment of HER2+ Metastatic Breast Cancer — Completed
• Sapanisertib in Combination With Fulvestrant in Women With Advanced or Metastatic Breast Cancer After Aromatase Inhibitor Therapy — Completed
• SPI-2012 vs Pegfilgrastim in the Management of Neutropenia in Participants With Breast Cancer With Docetaxel and Cyclophosphamide (ADVANCE) — Completed
• Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBC — Stopped early
• Phase III Study of DCVAC/PCa Added to Standard Chemotherapy for Men With Metastatic Castration Resistant Prostate Cancer — Completed
• A Study of PEGylated Recombinant Human Hyaluronidase (PEGPH20) With Pembrolizumab in Participants With Selected Hyaluronan High Solid Tumors — Completed
• Study of Azacitidine With or Without Birinapant in Subjects With MDS or CMMoL — Stopped early
• Safety and Exploratory Efficacy of Kanglaite Injection in Pancreatic Cancer — Completed